Talcum Powder Cancer Lawsuit

Johnson & Johnson Talcum Powder Spin-Off Bankruptcy Denied For A Second Time

Johnson & Johnson may now be held fully financially accountable for failing to warn consumers that asbestos lurked in their iconic baby powder

Wednesday, August 2, 2023 - Johnson & Johnson's second attempt at designating their LTL management subsidiary as bankrupt has failed. Judge Michael Kaplan of the U.S. Bankruptcy Court for the District of New Jersey has declared that the company has not met the logistic requirements that would grant them the protection of federal bankruptcy laws. LTL Management contains $8.9 billion in cash and many hundreds of times that amount in potential losses from lawsuits alleging that Johnson's Baby Powder caused ovarian cancer and mesothelioma, both death sentences for those unlucky enough to be diagnosed with either of them. According to the New York Times, " Judge Michael Kaplan of the U.S. Bankruptcy Court for the District of New Jersey, said LTL's bankruptcy case must be dismissed because the lawsuits did not put the company in "imminent or immediate financial distress." Earlier this year, the U.S. Court of Appeals for the Third Circuit in Philadelphia dismissed the first bankruptcy effort for the same reason." Plaintiff lawyers pleased with the decision to deny bankruptcy protection told the NYT that it was time for Johnson & Johnson, a financially healthy company to take financial responsibility for their reprehensible corporate conduct. "Andy Birchfield, a lawyer representing some of the cancer victims, said the ruling was a win for his clients. "J&J has spent two years trying to convince us that somehow a company worth a half-trillion dollars is bankrupt," he said. "It's time for the nonsense to stop and for J&J to accept responsibility," according to the NYT.

The judge's ruling may now open the door for talcum powder lawsuits against Johnson & Johnson to proceed. More than 38,000 people have filed talcum powder cancer lawsuits against the company and double that amount have registered their intent to file such a lawsuit with talcum powder cancer lawyers. The lawsuits were put on hold for two years as the company tried to implement an arcane financial scheme dubbed the Texas Two-Step. The TTS would have enabled Johnson & Johnson to place all of their current and future talcum powder cancer-related lawsuits into their LTL subsidiary and then declare it bankrupt. Johnson & Johnson offered the plaintiffs $8.9 billion to settle the claims and many talcum powder lawyers clients were willing to accept the deal. Lawyers representing Johnson & Johnson pledged to continue to work with counsel representing more than 60,000 talcum powder cancer claimants to try and come up with a settlement. Interestingly, Judge Kaplans ruling to deny the Johnson & Johnson bankruptcy comes after the conclusion of the single talcum powder cancer lawsuit that was allowed to proceed. A California man was awarded $18.9 million dollars in compensatory damages for the pericardial mesothelioma the jury agreed was caused by his mother's use of Johnson's Baby Powder on him regularly and repeatedly as a child during diaper changes. Punitive damages which could be as much as ten times the compensatory amount could be awarded in the days to come. The plaintiff has only weeks to live as his disease is aggressive and fatal, a condition which, under California law, enabled his case to be moved to the front of the line and be heard before his imminent demise.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.